Works by KIM, EUNSOOK


Results: 41
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
    By:
    • LIM, SOO;
    • KIM, GYURI;
    • KWON, HYUK-SANG;
    • PARK, IE BYUNG;
    • AHN, KYU JEUNG;
    • PARK, CHEOL-YOUNG;
    • KWON, SU KYOUNG;
    • KIM, HYE SOON;
    • PARK, SEOK WON;
    • KIM, SIN GON;
    • MOON, MIN KYONG;
    • KIM, EUNSOOK;
    • CHUNG, CHOON H.;
    • WON, KYU CHANG;
    • PARK, KANG SEO;
    • KIM, MIKYUNG;
    • CHUNG, DONG JIN;
    • LEE, CHANG BEOM;
    • KIM, TAE HO;
    • LEE, MOON-KYU
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Correction to: Editorial: Into a new decade.

    Published in:
    2022
    By:
    • Brysbaert, Marc;
    • Bakk, Zsuzsa;
    • Buchanan, Erin M.;
    • Drieghe, Denis;
    • Frey, Andreas;
    • Kim, Eunsook;
    • Kuperman, Victor;
    • Madan, Christopher R.;
    • Marelli, Marco;
    • Mathôt, Sebastiaan;
    • Valdivia, Dubravka Svetina;
    • Yap, Melvin
    Publication type:
    Correction Notice
    24

    Into a new decade.

    Published in:
    Behavior Research Methods, 2021, v. 53, n. 1, p. 1, doi. 10.3758/s13428-020-01497-y
    By:
    • Brysbaert, Marc;
    • Bakk, Zsuzsa;
    • Buchanan, Erin M.;
    • Drieghe, Denis;
    • Frey, Andreas;
    • Kim, Eunsook;
    • Kuperman, Victor;
    • Madan, Christopher R.;
    • Marelli, Marco;
    • Mathôt, Sebastiaan;
    • Svetina Valdivia, Dubravka;
    • Yap, Melvin
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1865, doi. 10.1111/dom.15046
    By:
    • Kwak, Soo Heon;
    • Han, Kyung Ah;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Kim, EunSook;
    • Won, Jong Chul;
    • Kang, Jun Goo;
    • Chung, Choon Hee;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Won, Kyu Chang;
    • Kim, Sin Gon;
    • Cho, Seung Ah;
    • Cho, Bo Young;
    • Park, Kyong Soo
    Publication type:
    Article
    40
    41